Podcast 849: Large Vessel Occlusions

Podcast 849: Large Vessel Occlusions

Up next

Podcast 1006: Cannabinoid Pharmacology

Contributor: Travis Barlock, MD Educational Pearls: Endocannabinoid System: THC binds CB1 and CB2 receptors in neurons and immune cells Δ9-Tetrahydrocannabinol (THC) is the main psychoactive compound in cannabis CB1 and CB2 receptors typically bind endogenously-produced 2-arachid ...  Show more

Podcast 1005: Balanced Fluid vs Normal Saline in Pediatric Patients

Contributor: Aaron Lessen, MD Educational Pearls: There has long been many questions about which IV fluid is best for ED resuscitation Multiple adult studies have shown no clear benefit of balanced fluid vs normal saline A large pediatric randomized clinical trial published in Ap ...  Show more

Recommended Episodes

158 - PADing Your Understanding of Peripheral Arterial Disease: A Brief Treatment Overview
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

In this episode, we will discuss all things peripheral arterial disease – definitions, staging, clinical presentation, risk factors, goals of therapy, and guideline-directed medication therapy recommendations including the newest evidence for the use of DOACs. Key Concepts Addres ...  Show more

Sept 16, 2022 This Week in Cardiology Podcast
This Week in Cardiology

The safety of very low LDL-C, the win-ratio analytic method, sacubitril/valsartan, SGLT2 inhibitors, and percutaneous left atrial appendage closure are discussed in this week's podcast.

This podcast is intended for healthcare professionals only. <u>To read a pa ...

  Show more

June 2 This Week in Cardiology
This Week in Cardiology

Listener feedback on the most important study in a decade, MONITOR-HF, a flawed paper and analysis, and the tension between pathos and logos are the topics John Mandrola, MD discusses in this week's podcast.

This podcast is intended for healthcare professionals only ...

  Show more

May 24 2024 This Week in Cardiology
This Week in Cardiology

Clues in SCAF, a DOAC antidote trial, another negative lytic trial in stroke, JAMA changes to observational studies, and BP in stroke care are the topics John Mandrola, MD, covers in this week's podcast.

This podcast is intended for healthcare professionals ...

  Show more